Chewy, Inc. CHWY
Composite 52/100; the shares have moved about 50% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 31/100 — a moderate mark against it.
Balance-sheet strength ranks 66/100 — a moderate point in its favour. Quality ranks 65/100 — a moderate point in its favour.
Momentum ranks 31/100 — a moderate mark against it. Valuation ranks 43/100 — a slight mark against it. Growth ranks 48/100 — a slight mark against it.
What the company does Chewy, Inc. (CHWY) operates an e-commerce platform specializing in pet food, supplies, medications, and health products, serving customers via websites and mobile apps, including its Autoship subscription service.
Key financials Chewy reports strong profitability metrics: ROE 64%, ROA 6%, ROCE 24%, and net margin 2.0%. Revenue grew 8% while EPS surged 53%. Gross margin stands at 30%, with operating and net margins at 3.8% and 2.0%, respectively. Debt/Equity is 1.23, interest coverage 50.46, and net debt/EBITDA 0.01.
Stock health Momentum is weak: -12% over 3 months, -26% over 6 months, and -37% over 12 months, with RSI at 60.80. The stock is -48% below its 52-week high. Sideravia scores Chewy as average quality (54.1/100), with weak momentum (19.1) but solid growth (68.0) and strength (64.5).
Price vs fair value CHWY trades at a PREMIUM of 19.90% versus our fair-value estimate of 18.27 and at a discount of 36.05% versus the analyst 12-month target of 31.05. - Recent headlines cite consumer pressure and stock declines despite profitable growth (Insider Monkey, Zacks). - Analysts note mixed sentiment, with some recommending the stock as a "growth stock to buy and hold" (Motley Fool).
Looking forward Forward P/E of 14.18 (vs. trailing 34.77) and PEG of 0.10 suggest potential valuation reset if growth sustains. High ROE and low net debt/EBITDA support operational resilience, but weak momentum and premium valuation may cap near-term upside.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.